<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-04-19T19:19:23Z</responseDate><request verb="GetRecord" identifier="oai:www.recercat.cat:2445/190125" metadataPrefix="qdc">https://recercat.cat/oai/request</request><GetRecord><record><header><identifier>oai:recercat.cat:2445/190125</identifier><datestamp>2025-12-05T04:23:23Z</datestamp><setSpec>com_2072_1057</setSpec><setSpec>col_2072_478809</setSpec><setSpec>col_2072_478917</setSpec></header><metadata><qdc:qualifieddc xmlns:qdc="http://dspace.org/qualifieddc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:doc="http://www.lyncode.com/xoai" xsi:schemaLocation="http://purl.org/dc/elements/1.1/ http://dublincore.org/schemas/xmls/qdc/2006/01/06/dc.xsd http://purl.org/dc/terms/ http://dublincore.org/schemas/xmls/qdc/2006/01/06/dcterms.xsd http://dspace.org/qualifieddc/ http://www.ukoln.ac.uk/metadata/dcmi/xmlschema/qualifieddc.xsd">
   <dc:title>Burden of ischemic heart disease in Spain: incidence, hospital mortality and costs of hospital care</dc:title>
   <dc:creator>Darbà, Josep</dc:creator>
   <dc:creator>Marsà, Alícia</dc:creator>
   <dc:subject>Política sanitària</dc:subject>
   <dc:subject>Cost de l'assistència sanitària</dc:subject>
   <dc:subject>Mortalitat</dc:subject>
   <dc:subject>Isquèmia</dc:subject>
   <dc:subject>Malalties cardiovasculars</dc:subject>
   <dc:subject>Medical policy</dc:subject>
   <dc:subject>Cost of medical care</dc:subject>
   <dc:subject>Mortality</dc:subject>
   <dc:subject>Ischemia</dc:subject>
   <dc:subject>Cardiovascular diseases</dc:subject>
   <dcterms:abstract>Ischemic heart disease (IHD) is the leading global cause of death and is assumed to entail a significant social and economic burden globally. This study aimed to evaluate incidence and mortality trends of IHD in Spain and to estimate direct medical costs (...)</dcterms:abstract>
   <dcterms:issued>2022-10-24T12:09:20Z</dcterms:issued>
   <dcterms:issued>2023-10-01T05:10:24Z</dcterms:issued>
   <dcterms:issued>2022-10-01</dcterms:issued>
   <dcterms:issued>2022-10-24T12:09:21Z</dcterms:issued>
   <dc:type>info:eu-repo/semantics/article</dc:type>
   <dc:type>info:eu-repo/semantics/acceptedVersion</dc:type>
   <dc:relation>Versió postprint del document publicat a: https://doi.org/10.1080/14737167.2022.2108794</dc:relation>
   <dc:relation>Expert Review of Pharmacoeconomics &amp; Outcomes Research, 2022, vol. 22, num. 7, p. 1147-1152</dc:relation>
   <dc:relation>https://doi.org/10.1080/14737167.2022.2108794</dc:relation>
   <dc:rights>(c) Informa Healthcare, 2022</dc:rights>
   <dc:rights>info:eu-repo/semantics/openAccess</dc:rights>
   <dc:publisher>Informa Healthcare</dc:publisher>
   <dc:source>Articles publicats en revistes (Economia)</dc:source>
</qdc:qualifieddc></metadata></record></GetRecord></OAI-PMH>